{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:51:58Z","timestamp":1783975918028,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extracellular microRNAs (miRNAs), released from cells into biofluids, have emerged as promising biomarkers for diagnostic and prognostic purposes. Several RNA isolation methods are available for the analysis of these cell-free miRNAs by RT-qPCR. Not all methods, however, are equally suitable for different biofluids. Here, we extracted total RNA from four very diverse biofluids: serum, urine, bile, and graft preservation fluid (perfusate). Four different protocols were used: a phenol-chloroform extraction and alcohol precipitation in combination with a precipitation carrier (QP) and three different column-based isolation methods, one with phenol-chloroform extraction (RN) and two without (NG and CU). For this range of clinical biofluid samples, we evaluated the potential of these different RNA isolation methods assessing recovery efficiency and the co-purification of RT-qPCR inhibiting compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Differences were observed between each of the RNA isolation methods in the recovery of cel-miR-39, a synthetic miRNA spiked in during the workup procedure, and for endogenous miRNAs. Co-purification of heparin, a known RT-qPCR inhibitor, was assessed using heparinase I during cDNA synthesis. RT-qPCR detection of synthetic miRNAs cel-miR-39, spiked in during RNA workup, cel-miR-54, spiked in during cDNA synthesis, and endogenous miRNAs was strongly improved in the presence of heparinase I for some, but not all, isolation methods. Other, co-isolated RT-qPCR inhibitors were not identified, except for biliverdin, which co-isolated from some bile samples with one of the methods. In addition, we observed that serum and urine contain compounds that enhance the binding of heparin to certain solid-phase columns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For reliable measurements of miRNA-based biomarkers in biofluids, optimization of RNA isolation procedures is recommended as methods can differ in miRNA detection and in co-purification of RT-qPCR inhibitory compounds. Heparinase I treatment confirmed that heparin appeared to be the major RT-qPCR inhibiting compound, but also biliverdin, co-isolated from bile, could interfere with detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12896-021-00706-6","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T03:03:23Z","timestamp":1628219003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-3807","authenticated-orcid":false,"given":"Henk P.","family":"Roest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan N. M.","family":"IJzermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J. W.","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"issue":"5571","key":"706_CR1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.1072249","volume":"296","author":"G Storz","year":"2002","unstructured":"Storz G. An expanding universe of noncoding RNAs. Science. 2002;296(5571):1260\u20133. https:\/\/doi.org\/10.1126\/science.1072249.","journal-title":"Science."},{"issue":"7006","key":"706_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135. https:\/\/doi.org\/10.1038\/nature02871.","journal-title":"Nature."},{"issue":"1","key":"706_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108.","journal-title":"Genome Res"},{"issue":"Database issue","key":"706_CR4","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42(Database issue):D68\u201373. https:\/\/doi.org\/10.1093\/nar\/gkt1181.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"706_CR5","doi-asserted-by":"publisher","first-page":"8731","DOI":"10.1093\/nar\/gkx595","volume":"45","author":"T Fehlmann","year":"2017","unstructured":"Fehlmann T, Backes C, Kahraman M, Haas J, Ludwig N, Posch AE, et al. Web-based NGS data analysis using miRMaster: a large-scale meta-analysis of human miRNAs. Nucleic Acids Res. 2017;45(15):8731\u201344. https:\/\/doi.org\/10.1093\/nar\/gkx595.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"706_CR6","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1242\/dev.02073","volume":"132","author":"I Alvarez-Garcia","year":"2005","unstructured":"Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132(21):4653\u201362. https:\/\/doi.org\/10.1242\/dev.02073.","journal-title":"Development."},{"issue":"10","key":"706_CR7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997\u20131006. https:\/\/doi.org\/10.1038\/cr.2008.282.","journal-title":"Cell Res"},{"issue":"2","key":"706_CR8","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/molecules19021912","volume":"19","author":"J Wang","year":"2014","unstructured":"Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19(2):1912\u201338. https:\/\/doi.org\/10.3390\/molecules19021912.","journal-title":"Molecules."},{"issue":"3","key":"706_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.trre.2014.03.003","volume":"28","author":"L Amrouche","year":"2014","unstructured":"Amrouche L, Rabant M, Anglicheau D. MicroRNAs as biomarkers of graft outcome. Transplant Rev (Orlando). 2014;28(3):111\u20138. https:\/\/doi.org\/10.1016\/j.trre.2014.03.003.","journal-title":"Transplant Rev (Orlando)"},{"issue":"12","key":"706_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4254\/wjh.v9.i12.586","volume":"9","author":"SH Loosen","year":"2017","unstructured":"Loosen SH, Schueller F, Trautwein C, Roy S, Roderburg C. Role of circulating microRNAs in liver diseases. World J Hepatol. 2017;9(12):586\u201394. https:\/\/doi.org\/10.4254\/wjh.v9.i12.586.","journal-title":"World J Hepatol"},{"issue":"2","key":"706_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","volume":"120","author":"J Viereck","year":"2017","unstructured":"Viereck J, Thum T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res. 2017;120(2):381\u201399. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308434.","journal-title":"Circ Res"},{"issue":"3","key":"706_CR12","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s12035-014-8944-x","volume":"52","author":"Y Zi","year":"2015","unstructured":"Zi Y, Yin Z, Xiao W, Liu X, Gao Z, Jiao L, et al. Circulating MicroRNA as potential source for neurodegenerative diseases biomarkers. Mol Neurobiol. 2015;52(3):1494\u2013503. https:\/\/doi.org\/10.1007\/s12035-014-8944-x.","journal-title":"Mol Neurobiol"},{"key":"706_CR13","doi-asserted-by":"publisher","first-page":"4072364","DOI":"10.1155\/2017\/4072364","volume":"2017","author":"M Hamdorf","year":"2017","unstructured":"Hamdorf M, Kawakita S, Everly M. The potential of MicroRNAs as novel biomarkers for transplant rejection. J Immunol Res. 2017;2017:4072364.","journal-title":"J Immunol Res"},{"issue":"11","key":"706_CR14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1373\/clinchem.2009.131797","volume":"55","author":"OF Laterza","year":"2009","unstructured":"Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, et al. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem. 2009;55(11):1977\u201383. https:\/\/doi.org\/10.1373\/clinchem.2009.131797.","journal-title":"Clin Chem"},{"issue":"1","key":"706_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-6143.2012.04313.x","volume":"13","author":"VR Mas","year":"2013","unstructured":"Mas VR, Dumur CI, Scian MJ, Gehrau RC, Maluf DG. MicroRNAs as biomarkers in solid organ transplantation. Am J Transplant. 2013;13(1):11\u20139. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04313.x.","journal-title":"Am J Transplant"},{"key":"706_CR16","doi-asserted-by":"crossref","unstructured":"Zhou M, Hara H, Dai Y, Mou L, Cooper DK, Wu C, et al. Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation. Int J Mol Sci. 2016;17(8):1232.","DOI":"10.3390\/ijms17081232"},{"issue":"6","key":"706_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2013.07.034","volume":"59","author":"CJ Verhoeven","year":"2013","unstructured":"Verhoeven CJ, Farid WR, de Ruiter PE, Hansen BE, Roest HP, de Jonge J, et al. MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation. J Hepatol. 2013;59(6):1231\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2013.07.034.","journal-title":"J Hepatol"},{"issue":"11","key":"706_CR18","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"JA Weber","year":"2010","unstructured":"Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56(11):1733\u201341. https:\/\/doi.org\/10.1373\/clinchem.2010.147405.","journal-title":"Clin Chem"},{"issue":"1","key":"706_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1155\/2012\/737169","volume":"33","author":"J Chen","year":"2012","unstructured":"Chen J, Kam-Tao P, Kwan BC, Chow KM, Lai KB, Luk CC, et al. Relation between microRNA expression in peritoneal dialysis effluent and peritoneal transport characteristics. Dis Markers. 2012;33(1):35\u201342. https:\/\/doi.org\/10.1155\/2012\/737169.","journal-title":"Dis Markers"},{"issue":"12","key":"706_CR20","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/resp.13364","volume":"23","author":"A Kishore","year":"2018","unstructured":"Kishore A, Navratilova Z, Kolek V, Novosadova E, Cepe K, du Bois RM, et al. Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respirology. 2018;23(12):1166\u201372. https:\/\/doi.org\/10.1111\/resp.13364.","journal-title":"Respirology."},{"issue":"8","key":"706_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023584","volume":"6","author":"K Shigehara","year":"2011","unstructured":"Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y, et al. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One. 2011;6(8):e23584. https:\/\/doi.org\/10.1371\/journal.pone.0023584.","journal-title":"PLoS One"},{"issue":"2","key":"706_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/TP.0000000000002527","volume":"103","author":"HP Roest","year":"2019","unstructured":"Roest HP, Ooms LSS, Gillis AJM, JNM IJ, Looijenga LHJ, Dorssers LCJ, et al. Cell-free MicroRNA miR-505-3p in graft preservation fluid is an independent predictor of delayed graft function after kidney transplantation. Transplantation. 2019;103(2):329\u201335. https:\/\/doi.org\/10.1097\/TP.0000000000002527.","journal-title":"Transplantation."},{"issue":"4","key":"706_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1586\/14737159.2016.1152184","volume":"16","author":"M Dellett","year":"2016","unstructured":"Dellett M, Simpson DA. Considerations for optimization of microRNA PCR assays for molecular diagnosis. Expert Rev Mol Diagn. 2016;16(4):407\u201314. https:\/\/doi.org\/10.1586\/14737159.2016.1152184.","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"706_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/lt.23872","volume":"20","author":"TO Lankisch","year":"2014","unstructured":"Lankisch TO, Voigtlander T, Manns MP, Holzmann A, Dangwal S, Thum T. MicroRNAs in the bile of patients with biliary strictures after liver transplantation. Liver Transpl. 2014;20(6):673\u20138. https:\/\/doi.org\/10.1002\/lt.23872.","journal-title":"Liver Transpl"},{"issue":"30","key":"706_CR25","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513\u20138. https:\/\/doi.org\/10.1073\/pnas.0804549105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"706_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2009.09.061","volume":"390","author":"M Mraz","year":"2009","unstructured":"Mraz M, Malinova K, Mayer J, Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun. 2009;390(1):1\u20134. https:\/\/doi.org\/10.1016\/j.bbrc.2009.09.061.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"706_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/liv.12955","volume":"36","author":"CJ Verhoeven","year":"2016","unstructured":"Verhoeven CJ, Farid WR, Roest HP, Ramakrishnaiah V, de Ruiter PE, de Jonge J, et al. Polarized release of hepatic microRNAs into bile and serum in response to cellular injury and impaired liver function. Liver Int. 2016;36(6):883\u201392. https:\/\/doi.org\/10.1111\/liv.12955.","journal-title":"Liver Int"},{"key":"706_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ab.2015.07.018","volume":"488","author":"A Brunet-Vega","year":"2015","unstructured":"Brunet-Vega A, Pericay C, Quilez ME, Ramirez-Lazaro MJ, Calvet X, Lario S. Variability in microRNA recovery from plasma: comparison of five commercial kits. Anal Biochem. 2015;488:28\u201335. https:\/\/doi.org\/10.1016\/j.ab.2015.07.018.","journal-title":"Anal Biochem"},{"issue":"4","key":"706_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.molimm.2012.02.001","volume":"50","author":"M Eldh","year":"2012","unstructured":"Eldh M, Lotvall J, Malmhall C, Ekstrom K. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol Immunol. 2012;50(4):278\u201386. https:\/\/doi.org\/10.1016\/j.molimm.2012.02.001.","journal-title":"Mol Immunol"},{"issue":"1","key":"706_CR30","doi-asserted-by":"publisher","first-page":"19529","DOI":"10.1038\/srep19529","volume":"6","author":"V El-Khoury","year":"2016","unstructured":"El-Khoury V, Pierson S, Kaoma T, Bernardin F, Berchem G. Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material. Sci Rep. 2016;6(1):19529. https:\/\/doi.org\/10.1038\/srep19529.","journal-title":"Sci Rep"},{"issue":"1","key":"706_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2164-15-395","volume":"15","author":"M Monleau","year":"2014","unstructured":"Monleau M, Bonnel S, Gostan T, Blanchard D, Courgnaud V, Lecellier CH. Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells. BMC Genomics. 2014;15(1):395. https:\/\/doi.org\/10.1186\/1471-2164-15-395.","journal-title":"BMC Genomics"},{"issue":"3","key":"706_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jcmm.12236","volume":"18","author":"L Moldovan","year":"2014","unstructured":"Moldovan L, Batte KE, Trgovcich J, Wisler J, Marsh CB, Piper M. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18(3):371\u201390. https:\/\/doi.org\/10.1111\/jcmm.12236.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"706_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1373\/clinchem.2012.199505","volume":"59","author":"JN Boeckel","year":"2013","unstructured":"Boeckel JN, Thome CE, Leistner D, Zeiher AM, Fichtlscherer S, Dimmeler S. Heparin selectively affects the quantification of microRNAs in human blood samples. Clin Chem. 2013;59(7):1125\u20137. https:\/\/doi.org\/10.1373\/clinchem.2012.199505.","journal-title":"Clin Chem"},{"issue":"1","key":"706_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2050-7771-2-13","volume":"2","author":"JL Plieskatt","year":"2014","unstructured":"Plieskatt JL, Feng Y, Rinaldi G, Mulvenna JP, Bethony JM, Brindley PJ. Circumventing qPCR inhibition to amplify miRNAs in plasma. Biomark Res. 2014;2(1):13. https:\/\/doi.org\/10.1186\/2050-7771-2-13.","journal-title":"Biomark Res"},{"issue":"6","key":"706_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jmoldx.2016.06.006","volume":"18","author":"HP Roest","year":"2016","unstructured":"Roest HP, Verhoeven CJ, de Haan JE, de Jonge J, van der Laan LJ JNIJ. Improving accuracy of urinary miRNA quantification in heparinized patients using Heparinase I digestion. J Mol Diagn. 2016;18(6):825\u201333. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.06.006.","journal-title":"J Mol Diagn"},{"issue":"6","key":"706_CR36","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jhep.2017.09.001","volume":"67","author":"CJ Verhoeven","year":"2017","unstructured":"Verhoeven CJ, Selten JW, Roest HP, Farid WRR, de Ruiter PE, Hansen BE, et al. Corrigendum to \"MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation\" [J Hepatol 2013; 59:1231-1238]. J Hepatol. 2017;67(6):1358\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2017.09.001.","journal-title":"J Hepatol"},{"issue":"2","key":"706_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cell.2019.03.024","volume":"177","author":"S Srinivasan","year":"2019","unstructured":"Srinivasan S, Yeri A, Cheah PS, Chung A, Danielson K, De Hoff P, et al. Small RNA sequencing across diverse biofluids identifies optimal methods for exRNA isolation. Cell. 2019;177(2):446\u201362 e16. https:\/\/doi.org\/10.1016\/j.cell.2019.03.024.","journal-title":"Cell."},{"issue":"5","key":"706_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.celrep.2018.10.014","volume":"25","author":"PM Godoy","year":"2018","unstructured":"Godoy PM, Bhakta NR, Barczak AJ, Cakmak H, Fisher S, MacKenzie TC, et al. Large differences in small RNA composition between human biofluids. Cell Rep. 2018;25(5):1346\u201358. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.014.","journal-title":"Cell Rep"},{"issue":"5","key":"706_CR39","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1365-2672.2012.05384.x","volume":"113","author":"C Schrader","year":"2012","unstructured":"Schrader C, Schielke A, Ellerbroek L, Johne R. PCR inhibitors - occurrence, properties and removal. J Appl Microbiol. 2012;113(5):1014\u201326. https:\/\/doi.org\/10.1111\/j.1365-2672.2012.05384.x.","journal-title":"J Appl Microbiol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-021-00706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-021-00706-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-021-00706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T03:05:23Z","timestamp":1628219123000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-021-00706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1186\/s12896-021-00706-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-107217\/v1","asserted-by":"object"}]},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Collection of peri-transplant materials from hospitalized individuals was approved by the Medical Ethical Council of the Erasmus MC and all participants provided written informed consent for the use of these materials for medical research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}